vs

Side-by-side financial comparison of Doximity, Inc. (DOCS) and SunOpta Inc. (STKL). Click either name above to swap in a different company.

SunOpta Inc. is the larger business by last-quarter revenue ($205.4M vs $185.1M, roughly 1.1× Doximity, Inc.). Doximity, Inc. runs the higher net margin — 33.3% vs 0.4%, a 32.9% gap on every dollar of revenue. On growth, SunOpta Inc. posted the faster year-over-year revenue change (16.6% vs 9.8%). Over the past eight quarters, Doximity, Inc.'s revenue compounded faster (25.2% CAGR vs 7.4%).

Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, telehealth tools, and case collaboration.

SunOpta, Inc. is a multi-national food and mineral company headquartered in Eden Prairie, Minnesota and founded in 1973 in Canada.

DOCS vs STKL — Head-to-Head

Bigger by revenue
STKL
STKL
1.1× larger
STKL
$205.4M
$185.1M
DOCS
Growing faster (revenue YoY)
STKL
STKL
+6.8% gap
STKL
16.6%
9.8%
DOCS
Higher net margin
DOCS
DOCS
32.9% more per $
DOCS
33.3%
0.4%
STKL
Faster 2-yr revenue CAGR
DOCS
DOCS
Annualised
DOCS
25.2%
7.4%
STKL

Income Statement — Q3 FY2026 vs Q3 FY2025

Metric
DOCS
DOCS
STKL
STKL
Revenue
$185.1M
$205.4M
Net Profit
$61.6M
$816.0K
Gross Margin
89.9%
12.4%
Operating Margin
38.9%
3.3%
Net Margin
33.3%
0.4%
Revenue YoY
9.8%
16.6%
Net Profit YoY
-18.1%
113.1%
EPS (diluted)
$0.31
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DOCS
DOCS
STKL
STKL
Q4 25
$185.1M
Q3 25
$168.5M
$205.4M
Q2 25
$145.9M
$191.5M
Q1 25
$138.3M
$201.6M
Q4 24
$168.6M
$193.9M
Q3 24
$136.8M
$175.9M
Q2 24
$126.7M
$169.5M
Q1 24
$118.1M
$184.4M
Net Profit
DOCS
DOCS
STKL
STKL
Q4 25
$61.6M
Q3 25
$62.1M
$816.0K
Q2 25
$53.3M
$4.4M
Q1 25
$62.5M
$4.8M
Q4 24
$75.2M
$-8.7M
Q3 24
$44.2M
$-6.2M
Q2 24
$41.4M
$-5.3M
Q1 24
$40.6M
$2.9M
Gross Margin
DOCS
DOCS
STKL
STKL
Q4 25
89.9%
Q3 25
90.3%
12.4%
Q2 25
89.2%
14.8%
Q1 25
89.5%
15.0%
Q4 24
91.6%
10.9%
Q3 24
90.0%
13.0%
Q2 24
89.3%
12.5%
Q1 24
89.4%
16.8%
Operating Margin
DOCS
DOCS
STKL
STKL
Q4 25
38.9%
Q3 25
37.8%
3.3%
Q2 25
37.4%
5.5%
Q1 25
35.2%
5.2%
Q4 24
47.4%
1.4%
Q3 24
38.8%
0.5%
Q2 24
36.4%
1.2%
Q1 24
35.5%
5.5%
Net Margin
DOCS
DOCS
STKL
STKL
Q4 25
33.3%
Q3 25
36.8%
0.4%
Q2 25
36.5%
2.3%
Q1 25
45.2%
2.4%
Q4 24
44.6%
-4.5%
Q3 24
32.3%
-3.5%
Q2 24
32.7%
-3.1%
Q1 24
34.4%
1.6%
EPS (diluted)
DOCS
DOCS
STKL
STKL
Q4 25
$0.31
Q3 25
$0.31
$0.01
Q2 25
$0.27
$0.03
Q1 25
$0.31
$0.04
Q4 24
$0.37
$-0.08
Q3 24
$0.22
$-0.05
Q2 24
$0.21
$-0.04
Q1 24
$0.20
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DOCS
DOCS
STKL
STKL
Cash + ST InvestmentsLiquidity on hand
$64.8M
$2.2M
Total DebtLower is stronger
$250.8M
Stockholders' EquityBook value
$979.3M
$162.8M
Total Assets
$1.2B
$694.1M
Debt / EquityLower = less leverage
1.54×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DOCS
DOCS
STKL
STKL
Q4 25
$64.8M
Q3 25
$169.2M
$2.2M
Q2 25
$137.3M
$2.2M
Q1 25
$209.6M
$2.3M
Q4 24
$165.3M
$1.6M
Q3 24
$184.2M
$2.9M
Q2 24
$111.4M
$3.2M
Q1 24
$96.8M
$1.5M
Total Debt
DOCS
DOCS
STKL
STKL
Q4 25
Q3 25
$250.8M
Q2 25
$263.3M
Q1 25
$260.6M
Q4 24
$265.2M
Q3 24
$289.9M
Q2 24
$303.1M
Q1 24
$258.8M
Stockholders' Equity
DOCS
DOCS
STKL
STKL
Q4 25
$979.3M
Q3 25
$1.1B
$162.8M
Q2 25
$1.0B
$159.8M
Q1 25
$1.1B
$154.8M
Q4 24
$1.0B
$148.6M
Q3 24
$961.2M
$155.0M
Q2 24
$913.6M
$158.8M
Q1 24
$901.4M
$163.6M
Total Assets
DOCS
DOCS
STKL
STKL
Q4 25
$1.2B
Q3 25
$1.3B
$694.1M
Q2 25
$1.2B
$704.9M
Q1 25
$1.3B
$690.7M
Q4 24
$1.2B
$668.5M
Q3 24
$1.1B
$699.3M
Q2 24
$1.1B
$704.7M
Q1 24
$1.1B
$671.8M
Debt / Equity
DOCS
DOCS
STKL
STKL
Q4 25
Q3 25
1.54×
Q2 25
1.65×
Q1 25
1.68×
Q4 24
1.78×
Q3 24
1.87×
Q2 24
1.91×
Q1 24
1.58×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DOCS
DOCS
STKL
STKL
Operating Cash FlowLast quarter
$60.9M
$16.3M
Free Cash FlowOCF − Capex
$12.1M
FCF MarginFCF / Revenue
5.9%
Capex IntensityCapex / Revenue
2.1%
Cash ConversionOCF / Net Profit
0.99×
20.03×
TTM Free Cash FlowTrailing 4 quarters
$36.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DOCS
DOCS
STKL
STKL
Q4 25
$60.9M
Q3 25
$93.9M
$16.3M
Q2 25
$62.1M
$-4.5M
Q1 25
$98.5M
$22.3M
Q4 24
$65.2M
$33.1M
Q3 24
$68.3M
$17.2M
Q2 24
$41.2M
$-5.6M
Q1 24
$63.9M
$5.3M
Free Cash Flow
DOCS
DOCS
STKL
STKL
Q4 25
Q3 25
$12.1M
Q2 25
$-9.2M
Q1 25
$9.5M
Q4 24
$24.0M
Q3 24
$11.7M
Q2 24
$-15.3M
Q1 24
$-2.3M
FCF Margin
DOCS
DOCS
STKL
STKL
Q4 25
Q3 25
5.9%
Q2 25
-4.8%
Q1 25
4.7%
Q4 24
12.4%
Q3 24
6.6%
Q2 24
-9.0%
Q1 24
-1.2%
Capex Intensity
DOCS
DOCS
STKL
STKL
Q4 25
Q3 25
2.1%
Q2 25
2.5%
Q1 25
0.0%
6.3%
Q4 24
0.0%
4.7%
Q3 24
0.0%
3.2%
Q2 24
0.0%
5.7%
Q1 24
0.0%
4.1%
Cash Conversion
DOCS
DOCS
STKL
STKL
Q4 25
0.99×
Q3 25
1.51×
20.03×
Q2 25
1.16×
-1.03×
Q1 25
1.58×
4.63×
Q4 24
0.87×
Q3 24
1.55×
Q2 24
1.00×
Q1 24
1.57×
1.83×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DOCS
DOCS

Subscription$175.4M95%
Service Other$9.7M5%

STKL
STKL

Beverages And Broths$161.4M79%
Fruit Snacks$40.9M20%
Ingredients$3.1M2%

Related Comparisons